Albemarle Corporation (ALB) Shares Bought by Janus Henderson Group PLC

Janus Henderson Group PLC grew its position in Albemarle Corporation (NYSE:ALB) by 907.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 817,035 shares of the specialty chemicals company’s stock after buying an additional 735,956 shares during the quarter. Janus Henderson Group PLC owned 0.74% of Albemarle Corporation worth $86,230,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in ALB. Carroll Financial Associates Inc. increased its position in Albemarle Corporation by 0.3% during the 2nd quarter. Carroll Financial Associates Inc. now owns 982 shares of the specialty chemicals company’s stock worth $103,000 after purchasing an additional 3 shares in the last quarter. Benjamin F. Edwards & Company Inc. boosted its stake in Albemarle Corporation by 0.3% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 1,458 shares of the specialty chemicals company’s stock worth $154,000 after buying an additional 4 shares during the last quarter. Alps Advisors Inc. boosted its stake in Albemarle Corporation by 0.3% in the 2nd quarter. Alps Advisors Inc. now owns 4,606 shares of the specialty chemicals company’s stock worth $486,000 after buying an additional 12 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its stake in Albemarle Corporation by 2.1% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 968 shares of the specialty chemicals company’s stock worth $102,000 after buying an additional 20 shares during the last quarter. Finally, Benedict Financial Advisors Inc. boosted its stake in Albemarle Corporation by 0.3% in the 2nd quarter. Benedict Financial Advisors Inc. now owns 7,233 shares of the specialty chemicals company’s stock worth $856,000 after buying an additional 21 shares during the last quarter. Institutional investors and hedge funds own 83.77% of the company’s stock.

In related news, EVP Matthew Juneau sold 5,397 shares of the firm’s stock in a transaction on Thursday, August 24th. The stock was sold at an average price of $115.77, for a total transaction of $624,810.69. Following the sale, the executive vice president now owns 360 shares of the company’s stock, valued at approximately $41,677.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Karen G. Narwold sold 11,500 shares of the firm’s stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $115.95, for a total value of $1,333,425.00. Following the sale, the executive vice president now directly owns 36,620 shares in the company, valued at approximately $4,246,089. The disclosure for this sale can be found here. 0.74% of the stock is owned by company insiders.

Shares of Albemarle Corporation (ALB) opened at 137.77 on Wednesday. The firm has a market cap of $15.22 billion, a price-to-earnings ratio of 17.62 and a beta of 1.67. Albemarle Corporation has a one year low of $76.32 and a one year high of $140.10. The stock has a 50 day moving average price of $126.58 and a 200 day moving average price of $114.71.

Albemarle Corporation (NYSE:ALB) last posted its quarterly earnings results on Monday, August 7th. The specialty chemicals company reported $1.13 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.11 by $0.02. Albemarle Corporation had a return on equity of 11.59% and a net margin of 31.49%. The business had revenue of $737.25 million for the quarter, compared to analyst estimates of $735.50 million. During the same period last year, the company earned $0.93 EPS. The firm’s revenue was up 10.1% on a year-over-year basis. On average, equities research analysts forecast that Albemarle Corporation will post $4.37 EPS for the current year.

TRADEMARK VIOLATION NOTICE: “Albemarle Corporation (ALB) Shares Bought by Janus Henderson Group PLC” was first published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this news story on another site, it was copied illegally and reposted in violation of US & international copyright law. The original version of this news story can be accessed at https://ledgergazette.com/2017/10/11/albemarle-corporation-alb-shares-bought-by-janus-henderson-group-plc.html.

Several equities analysts have recently weighed in on ALB shares. Zacks Investment Research raised Albemarle Corporation from a “hold” rating to a “buy” rating and set a $121.00 price objective on the stock in a research note on Friday, July 7th. Robert W. Baird reiterated an “outperform” rating and set a $135.00 target price (up from $125.00) on shares of Albemarle Corporation in a report on Tuesday, July 18th. They noted that the move was a valuation call. BidaskClub downgraded Albemarle Corporation from a 

Several other hedge funds have also recently made changes to their positions in ALB. Carroll Financial Associates Inc. increased its position in Albemarle Corporation by 0.3% during the 2nd quarter. Carroll Financial Associates Inc. now owns 982 shares of the specialty chemicals company’s stock worth $103,000 after purchasing an additional 3 shares in the last quarter. Benjamin F. Edwards & Company Inc. boosted its stake in Albemarle Corporation by 0.3% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 1,458 shares of the specialty chemicals company’s stock worth $154,000 after buying an additional 4 shares during the last quarter. Alps Advisors Inc. boosted its stake in Albemarle Corporation by 0.3% in the 2nd quarter. Alps Advisors Inc. now owns 4,606 shares of the specialty chemicals company’s stock worth $486,000 after buying an additional 12 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its stake in Albemarle Corporation by 2.1% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 968 shares of the specialty chemicals company’s stock worth $102,000 after buying an additional 20 shares during the last quarter. Finally, Benedict Financial Advisors Inc. boosted its stake in Albemarle Corporation by 0.3% in the 2nd quarter. Benedict Financial Advisors Inc. now owns 7,233 shares of the specialty chemicals company’s stock worth $856,000 after buying an additional 21 shares during the last quarter. Institutional investors and hedge funds own 83.77% of the company’s stock.

In related news, EVP Matthew Juneau sold 5,397 shares of the firm’s stock in a transaction on Thursday, August 24th. The stock was sold at an average price of $115.77, for a total transaction of $624,810.69. Following the sale, the executive vice president now owns 360 shares of the company’s stock, valued at approximately $41,677.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Karen G. Narwold sold 11,500 shares of the firm’s stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $115.95, for a total value of $1,333,425.00. Following the sale, the executive vice president now directly owns 36,620 shares in the company, valued at approximately $4,246,089. The disclosure for this sale can be found here. 0.74% of the stock is owned by company insiders.

Shares of Albemarle Corporation (ALB) opened at 137.77 on Wednesday. The firm has a market cap of $15.22 billion, a price-to-earnings ratio of 17.62 and a beta of 1.67. Albemarle Corporation has a one year low of $76.32 and a one year high of $140.10. The stock has a 50 day moving average price of $126.58 and a 200 day moving average price of $114.71.

Albemarle Corporation (NYSE:ALB) last posted its quarterly earnings results on Monday, August 7th. The specialty chemicals company reported $1.13 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.11 by $0.02. Albemarle Corporation had a return on equity of 11.59% and a net margin of 31.49%. The business had revenue of $737.25 million for the quarter, compared to analyst estimates of $735.50 million. During the same period last year, the company earned $0.93 EPS. The firm’s revenue was up 10.1% on a year-over-year basis. On average, equities research analysts forecast that Albemarle Corporation will post $4.37 EPS for the current year.

TRADEMARK VIOLATION NOTICE: “Albemarle Corporation (ALB) Shares Bought by Janus Henderson Group PLC” was first published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this news story on another site, it was copied illegally and reposted in violation of US & international copyright law. The original version of this news story can be accessed at https://ledgergazette.com/2017/10/11/albemarle-corporation-alb-shares-bought-by-janus-henderson-group-plc.html.

Several equities analysts have recently weighed in on ALB shares. Zacks Investment Research raised Albemarle Corporation from a “hold” rating to a “buy” rating and set a $121.00 price objective on the stock in a research note on Friday, July 7th. Robert W. Baird reiterated an “outperform” rating and set a $135.00 target price (up from $125.00) on shares of Albemarle Corporation in a report on Tuesday, July 18th. They noted that the move was a valuation call. BidaskClub downgraded Albemarle Corporation from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 25th. Needham & Company LLC reiterated a “buy” rating and set a $36.00 target price on shares of Albemarle Corporation in a report on Thursday, June 29th. Finally, Jefferies Group LLC reiterated a “buy” rating and set a $120.00 target price on shares of Albemarle Corporation in a report on Friday, June 16th. Nine analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. Albemarle Corporation currently has a consensus rating of “Buy” and a consensus target price of $118.05.

Albemarle Corporation Company Profile

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Institutional Ownership by Quarter for Albemarle Corporation (NYSE:ALB)

Receive News & Ratings for Albemarle Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply